ADCT股价有吸引力

来源: algo 于 2023-04-01 15:48:20 [] [旧帖] [给我悄悄话] 阅读数 : (2738 bytes)
本帖于 2023-04-01 15:49:13 时间, 由普通用户 algo 编辑

ADCT is one of the top Antibody-Drug Conjugate (ADC) contenders on the market with a large pipeline and an already approved ADC (Zynlonta), which is now selling in the US and approved in Europe. Europe sales begin in 2Q23. (about 2 weeks from now)

Recent big name buyouts in the ADC space were:

1.) Gilead bought Immunomedics - $20Billion

2.) Pfizer bought Seagen - $43Billion

Merck got beat out by Pfizer when they bought Seagen just recently.

I'm sure Merck is still on the hunt for another top ADC company with a rich pipeline like ADCT.

Hope we are on the radar for the next Buyout!

所有跟帖： 

• PFE 收购 SGEN，是为了解决专利到期而来的营收下降问题 -三丝- ♂ 给 三丝 发送悄悄话 (0 bytes) () 04/01/2023 postreply 18:46:53

• 期望到2030年，SGEN可以给PFE带来10B -三丝- ♂ 给 三丝 发送悄悄话 (0 bytes) () 04/01/2023 postreply 18:48:05

• 所以INCY可能是下一个目标，其余做ADC的公司还太小 -三丝- ♂ 给 三丝 发送悄悄话 (0 bytes) () 04/01/2023 postreply 18:49:57

请您先登陆，再发跟帖！